Efficacy and safety of lacosamide in patients with erythromelalgia due to SCN9A gene mutatio
Not Applicable
Recruiting
- Conditions
- erythromelalgia
- Registration Number
- JPRN-UMIN000028778
- Lead Sponsor
- niversity of the Ryukyus Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 1
Inclusion Criteria
Not provided
Exclusion Criteria
A case with kidney dysfunction A case with significant ECG abnormality A Case who is considered by doctor to be inappropriate for administration of lacosamide.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Amount of change in scoring below 8 weeks after starting lacosamide administration Pain Intensity Numerical Rating Scale Daily sleep interference scale
- Secondary Outcome Measures
Name Time Method